Main > HEMATOLOGY > Neutropenia(N)>Severe Chronic N. > Treatment > Thrombopoietin > Purification

Product USA. Z

PATENT ASSIGNEE'S COUNTRY USA
UPDATE 11.99
PATENT ASSIGNEE This data is not available for free
PATENT CLAIMS - Applying biol. fluid contg thrombopoietin to protein compri
sing ligand-binding domain of an MPL receptor, which pro
tein is bound to solid support, whereby said thrombopoie
tin is adsorbed to said protein
- Washing the protein to elute ybadsorbed material
- Eluting the adsorbed thrombopoietin from said protein
- Fractionating the eluted TPO by anion exchange chromato
graphy &
- Collecting the fractionated TPO;
Wherein collected TPO is characterized by
- MW 60000-80000 as determined by SDS-PAGE under
denaturing conditions
- > 90% pure with respect to contaminating proteins as deter
mined by SDS-PAGE & Ag staining
- Free of TPO species of MW < 55 kD
- Stimulates MPL-dependent cell proliferation
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back